A Phase I Study to Investigate the ADME of KD101

NCT02819934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: KD101

Sponsor

Seoul National University Hospital